Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Lexeo Therapeutics, Inc. shareholders
As of Sep 30, 2026, 149 institutions reported holding Lexeo Therapeutics, Inc. Largest: Affinity Asset Advisors, LLC, Montanova Capital, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Lexeo Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 7.25M | +1.44M | Nov 13, 2026 | |
| Montanova Capital, LLC | 6.38M | no change | Nov 16, 2026 | |
| BlackRock | 5.97M | +234K | Nov 13, 2026 | |
| Ra Capital Management, L.P. | 5M | no change | Nov 16, 2026 | |
| Frazier Life Sciences Management, L.P. | 4.82M | no change | Nov 16, 2026 | |
| JPMorgan | 4.58M | +4.49M | Nov 12, 2026 | |
| Vestal Point Capital, LP | 4.32M | no change | Nov 16, 2026 | |
| Citadel | 4.24M | +338K | Nov 16, 2026 | |
| Vanguard | 4.21M | −6,631 | Nov 16, 2026 | |
| Balyasny Asset Management L.P. | 3.99M | +1.58M | Nov 16, 2026 |